Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.
2.

The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.

Paul B, Li Y, Tollefsbol TO.

Int J Mol Sci. 2018 Jun 13;19(6). pii: E1754. doi: 10.3390/ijms19061754.

3.

Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.

Royston KJ, Paul B, Nozell S, Rajbhandari R, Tollefsbol TO.

Exp Cell Res. 2018 Jul 1;368(1):67-74. doi: 10.1016/j.yexcr.2018.04.015. Epub 2018 Apr 22.

PMID:
29689276
4.

The Role of Non-Coding RNAs and Isothiocyanates in Cancer.

Martin SL, Royston KJ, Tollefsbol TO.

Mol Nutr Food Res. 2018 Mar 12:e1700913. doi: 10.1002/mnfr.201700913. [Epub ahead of print] Review.

PMID:
29532604
5.

Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.

Paul B, Royston KJ, Li Y, Stoll ML, Skibola CF, Wilson LS, Barnes S, Morrow CD, Tollefsbol TO.

PLoS One. 2017 Dec 21;12(12):e0189756. doi: 10.1371/journal.pone.0189756. eCollection 2017.

6.

Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.

García-Giménez JL, Seco-Cervera M, Tollefsbol TO, Romá-Mateo C, Peiró-Chova L, Lapunzina P, Pallardó FV.

Crit Rev Clin Lab Sci. 2017 Nov - Dec;54(7-8):529-550. doi: 10.1080/10408363.2017.1410520. Epub 2017 Dec 11. Review.

PMID:
29226748
7.

Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.

Daniel M, Tollefsbol TO.

J Cell Biochem. 2018 Apr;119(4):3326-3337. doi: 10.1002/jcb.26495. Epub 2017 Dec 26.

8.
9.

The influence of an epigenetics diet on the cancer epigenome.

Lewis KA, Tollefsbol TO.

Epigenomics. 2017 Sep;9(9):1153-1155. doi: 10.2217/epi-2017-0077. Epub 2017 Aug 11. No abstract available.

10.

A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.

Royston KJ, Udayakumar N, Lewis K, Tollefsbol TO.

Int J Mol Sci. 2017 May 19;18(5). pii: E1092. doi: 10.3390/ijms18051092.

11.

Transforming Cancer Epigenetics Using Nutritive Approaches and Noncoding RNAs.

Dates CR, Tollefsbol TO.

Curr Cancer Drug Targets. 2018;18(1):32-38. doi: 10.2174/1568009617666170203165326.

12.
13.
14.

Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.

Li Y, Buckhaults P, Cui X, Tollefsbol TO.

Epigenomics. 2016 Aug;8(8):1019-37. doi: 10.2217/epi-2016-0024. Epub 2016 Aug 1.

15.

Erratum to "Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 cancer cells with PX-866 and Raloxifene" [Exp. Cell Res. 344 (2016) 95-102].

Peek GW, Tollefsbol TO.

Exp Cell Res. 2016 Jul 15;345(2):255. doi: 10.1016/j.yexcr.2016.05.021. Epub 2016 Jun 2. No abstract available.

PMID:
27265745
16.

Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms.

Lewis KA, Tollefsbol TO.

Front Genet. 2016 May 9;7:83. doi: 10.3389/fgene.2016.00083. eCollection 2016. Review.

17.
18.

Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

Peek GW, Tollefsbol TO.

Exp Cell Res. 2016 May 15;344(1):95-102. doi: 10.1016/j.yexcr.2016.03.022. Epub 2016 Mar 23.

19.

Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing.

Saldanha SN, Royston KJ, Udayakumar N, Tollefsbol TO.

Int J Mol Sci. 2015 Dec 24;17(1). pii: E16. doi: 10.3390/ijms17010016. Review.

20.

Combinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.

Peek GW, Tollefsbol TO.

J Cell Biochem. 2016 Jul;117(7):1688-96. doi: 10.1002/jcb.25462. Epub 2015 Dec 28.

Supplemental Content

Loading ...
Support Center